|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
180 a.a.*
|
 |
|
|
|
|
|
|
|
380 a.a.*
|
 |
|
|
|
|
|
|
|
370 a.a.*
|
 |
|
|
|
|
|
|
|
90 a.a.*
|
 |
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Blood clotting
|
 |
|
Title:
|
 |
The crystal structure of modified bovine fibrinogen (at ~4 angstrom resolution)
|
|
Structure:
|
 |
Fibrinogen (alpha chain). Chain: a, d, n, q. Fragment: pseudomonas aeruginosa ps-1-modified fragment. Fibrinogen (beta chain). Chain: b, e, o, r. Fragment: pseudomonas aeruginosa ps-1-modified fragment. Fibrinogen (gamma chain). Chain: c, f, p, s. Fragment: pseudomonas aeruginosa ps-1-modified fragment.
|
|
Source:
|
 |
Bos taurus. Cattle. Organism_taxid: 9913. Organism_taxid: 9913
|
|
Biol. unit:
|
 |
Heptamer (from
)
|
|
Resolution:
|
 |
|
3.50Å
|
R-factor:
|
0.257
|
R-free:
|
0.370
|
|
|
Authors:
|
 |
J.H.Brown,N.Volkmann,G.Jun,A.H.Henschen-Edman,C.Cohen
|
Key ref:
|
 |
J.H.Brown
et al.
(2000).
The crystal structure of modified bovine fibrinogen.
Proc Natl Acad Sci U S A,
97,
85-90.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-Nov-99
|
Release date:
|
02-Feb-00
|
|
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P02672
(FIBA_BOVIN) -
Fibrinogen alpha chain from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
615 a.a.
180 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P02676
(FIBB_BOVIN) -
Fibrinogen beta chain from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
468 a.a.
380 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
97:85-90
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of modified bovine fibrinogen.
|
|
J.H.Brown,
N.Volkmann,
G.Jun,
A.H.Henschen-Edman,
C.Cohen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Here we report the crystal structure at approximately 4-A resolution of a
selectively proteolyzed bovine fibrinogen. This key component in hemostasis is
an elongated 340-kDa glycoprotein in the plasma that upon activation by thrombin
self-assembles to form the fibrin clot. The crystals are unusual because they
are made up of end-to-end bonded molecules that form flexible filaments. We have
visualized the entire coiled-coil region of the molecule, which has a planar
sigmoidal shape. The primary polymerization receptor pockets at the ends of the
molecule face the same way throughout the end-to-end bonded filaments, and based
on this conformation, we have developed an improved model of the two-stranded
protofibril that is the basic building block in fibrin. Near the middle of the
coiled-coil region, the plasmin-sensitive segment is a hinge about which the
molecule adopts different conformations. This segment also includes the boundary
between the three- and four-stranded portions of the coiled coil, indicating the
location on the backbone that anchors the extended flexible Aalpha arm. We
suggest that a flexible branch point in the molecule may help accommodate
variability in the structure of the fibrin clot.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Conformational flexibility of fibrinogen in the
crystals. The diagrams show superpositions of
noncrystallographically related fibrinogen molecules based on
the least-squares fit of the relatively rigid coiled-coil
segment: A 104-A 154, B 140-B 190, 77- 127. Among
the different noncrystallographically related copies, the rms
difference between the coordinates of this segment is about half
that of the backbone's most flexible segment: A 64-A 114, B 100-B 150, 37- 87. (a)
View, as in Fig. 1a, of one pair of molecules whose
conformations differ primarily by bending within the plane of
the sigmoidal coiled-coil axis. (b) View, as in Fig. 1b, of a
different pair of molecules whose conformations differ primarily
by bending out of the plane of the sigmoidal axis.
|
 |
Figure 3.
Fig. 3. Conserved end-to-end molecular interactions. (a)
Superposition of six -domain
dimers derived from the various crystals of modified bovine
fibrinogen (red) and human fragment D and crosslinked D-dimer
(blue) (24, 25) show the domains to
be similarly "offset" from one another. This feature can be
visualized by noting, for example, that 264 of the
right monomer is interacting at the edge of the - interface
whereas in the left monomer it is interacting at the center of
the interface. No significant difference in the offset is found
among the three bovine -domain
dimers or among the three human -domain
dimers (pooled intra-species SD is 0.455 Å). Interspecies
amino acid differences at or near the interface (e.g., 264, which
is methionine in human and serine in bovine fibrinogen) probably
perturb the docking of the domains, creating a slightly less
staggered offset ( 1.7-Å
rms difference) in the bovine -dimer
relative to that in the human dimer. (b) Crystal structure of an
end-to-end bonded fibrinogen filament. All -domain
receptor pockets (shown by arrows) are on the same face of the
extended filament.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.R.Carlisle,
C.Coulais,
M.Namboothiry,
D.L.Carroll,
R.R.Hantgan,
and
M.Guthold
(2009).
The mechanical properties of individual, electrospun fibrinogen fibers.
|
| |
Biomaterials,
30,
1205-1213.
|
 |
|
|
|
|
 |
G.Tsurupa,
R.R.Hantgan,
R.A.Burton,
I.Pechik,
N.Tjandra,
and
L.Medved
(2009).
Structure, stability, and interaction of the fibrin(ogen) alphaC-domains.
|
| |
Biochemistry,
48,
12191-12201.
|
 |
|
|
|
|
 |
J.K.Ryu,
D.Davalos,
and
K.Akassoglou
(2009).
Fibrinogen signal transduction in the nervous system.
|
| |
J Thromb Haemost,
7,
151-154.
|
 |
|
|
|
|
 |
J.W.Weisel
(2009).
Why dysfibrinogenaemias still matter.
|
| |
Thromb Haemost,
102,
426-427.
|
 |
|
|
|
|
 |
L.Medved,
and
J.W.Weisel
(2009).
Recommendations for nomenclature on fibrinogen and fibrin.
|
| |
J Thromb Haemost,
7,
355-359.
|
 |
|
|
|
|
 |
E.T.O'Brien,
M.R.Falvo,
D.Millard,
B.Eastwood,
R.M.Taylor,
and
R.Superfine
(2008).
Ultrathin self-assembled fibrin sheets.
|
| |
Proc Natl Acad Sci U S A,
105,
19438-19443.
|
 |
|
|
|
|
 |
V.Castelletto,
G.E.Newby,
and
I.W.Hamley
(2008).
Interactions of KLVFF-PEG peptide conjugate with fibrinogen in neutral aqueous solutions.
|
| |
Macromol Biosci,
8,
1182-1189.
|
 |
|
|
|
|
 |
A.E.Brown,
R.I.Litvinov,
D.E.Discher,
and
J.W.Weisel
(2007).
Forced unfolding of coiled-coils in fibrinogen by single-molecule AFM.
|
| |
Biophys J,
92,
L39-L41.
|
 |
|
|
|
|
 |
E.A.Scott,
and
D.L.Elbert
(2007).
Mass spectrometric mapping of fibrinogen conformations at poly(ethylene terephthalate) interfaces.
|
| |
Biomaterials,
28,
3904-3917.
|
 |
|
|
|
|
 |
M.Guthold,
W.Liu,
E.A.Sparks,
L.M.Jawerth,
L.Peng,
M.Falvo,
R.Superfine,
R.R.Hantgan,
and
S.T.Lord
(2007).
A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers.
|
| |
Cell Biochem Biophys,
49,
165-181.
|
 |
|
|
|
|
 |
R.A.Burton,
G.Tsurupa,
R.R.Hantgan,
N.Tjandra,
and
L.Medved
(2007).
NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.
|
| |
Biochemistry,
46,
8550-8560.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.I.Litvinov,
S.Yakovlev,
G.Tsurupa,
O.V.Gorkun,
L.Medved,
and
J.W.Weisel
(2007).
Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
|
| |
Biochemistry,
46,
9133-9142.
|
 |
|
|
|
|
 |
V.H.Flood,
C.Nagaswami,
I.N.Chernysh,
H.A.Al-Mondhiry,
J.W.Weisel,
and
D.H.Farrell
(2007).
Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
|
| |
Br J Haematol,
138,
117-124.
|
 |
|
|
|
|
 |
I.Pechik,
S.Yakovlev,
M.W.Mosesson,
G.L.Gilliland,
and
L.Medved
(2006).
Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
|
| |
Biochemistry,
45,
3588-3597.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.H.Brown
(2006).
Breaking symmetry in protein dimers: designs and functions.
|
| |
Protein Sci,
15,
1.
|
 |
|
|
|
|
 |
P.Panizzi,
R.Friedrich,
P.Fuentes-Prior,
K.Richter,
P.E.Bock,
and
W.Bode
(2006).
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
|
| |
J Biol Chem,
281,
1179-1187.
|
 |
|
|
|
|
 |
R.A.Burton,
G.Tsurupa,
L.Medved,
and
N.Tjandra
(2006).
Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR.
|
| |
Biochemistry,
45,
2257-2266.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Asselta,
S.Duga,
and
M.L.Tenchini
(2006).
The molecular basis of quantitative fibrinogen disorders.
|
| |
J Thromb Haemost,
4,
2115-2129.
|
 |
|
|
|
|
 |
R.F.Doolittle,
and
J.M.Kollman
(2006).
Natively unfolded regions of the vertebrate fibrinogen molecule.
|
| |
Proteins,
63,
391-397.
|
 |
|
|
|
|
 |
S.B.Kim,
D.W.Lee,
C.I.Cheigh,
E.A.Choe,
S.J.Lee,
Y.H.Hong,
H.J.Choi,
and
Y.R.Pyun
(2006).
Purification and characterization of a fibrinolytic subtilisin-like protease of Bacillus subtilis TP-6 from an Indonesian fermented soybean, Tempeh.
|
| |
J Ind Microbiol Biotechnol,
33,
436-444.
|
 |
|
|
|
|
 |
S.Ohnishi,
E.S.Garfein,
S.J.Karp,
and
J.V.Frangioni
(2006).
Radiolabeled and near-infrared fluorescent fibrinogen derivatives create a system for the identification and repair of obscure gastrointestinal bleeding.
|
| |
Surgery,
140,
785-792.
|
 |
|
|
|
|
 |
T.Sugo,
H.Endo,
M.Matsuda,
T.Ohmori,
S.Madoiwa,
J.Mimuro,
and
Y.Sakata
(2006).
A classification of the fibrin network structures formed from the hereditary dysfibrinogens.
|
| |
J Thromb Haemost,
4,
1738-1746.
|
 |
|
|
|
|
 |
J.P.Collet,
H.Shuman,
R.E.Ledger,
S.Lee,
and
J.W.Weisel
(2005).
The elasticity of an individual fibrin fiber in a clot.
|
| |
Proc Natl Acad Sci U S A,
102,
9133-9137.
|
 |
|
|
|
|
 |
B.Rubin,
and
G.Sønderstrup
(2004).
Citrullination of self-proteins and autoimmunity.
|
| |
Scand J Immunol,
60,
112-120.
|
 |
|
|
|
|
 |
D.H.Farrell
(2004).
Pathophysiologic roles of the fibrinogen gamma chain.
|
| |
Curr Opin Hematol,
11,
151-155.
|
 |
|
|
|
|
 |
J.W.Weisel
(2004).
Cross-linked gamma-chains in fibrin fibrils bridge transversely between strands: no.
|
| |
J Thromb Haemost,
2,
394-399.
|
 |
|
|
|
|
 |
M.Guthold,
W.Liu,
B.Stephens,
S.T.Lord,
R.R.Hantgan,
D.A.Erie,
R.M.Taylor,
and
R.Superfine
(2004).
Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3.
|
| |
Biophys J,
87,
4226-4236.
|
 |
|
|
|
|
 |
R.F.Doolittle
(2004).
Determining the crystal structure of fibrinogen.
|
| |
J Thromb Haemost,
2,
683-689.
|
 |
|
|
|
|
 |
A.Profumo,
M.Turci,
G.Damonte,
F.Ferri,
D.Magatti,
B.Cardinali,
C.Cuniberti,
and
M.Rocco
(2003).
Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
|
| |
Biochemistry,
42,
12335-12348.
|
 |
|
|
|
|
 |
C.A.Staton,
N.J.Brown,
and
C.E.Lewis
(2003).
The role of fibrinogen and related fragments in tumour angiogenesis and metastasis.
|
| |
Expert Opin Biol Ther,
3,
1105-1120.
|
 |
|
|
|
|
 |
R.F.Doolittle
(2003).
X-ray crystallographic studies on fibrinogen and fibrin.
|
| |
J Thromb Haemost,
1,
1559-1565.
|
 |
|
|
|
|
 |
R.F.Doolittle
(2003).
Structural basis of the fibrinogen-fibrin transformation: contributions from X-ray crystallography.
|
| |
Blood Rev,
17,
33-41.
|
 |
|
|
|
|
 |
F.Ferri,
M.Greco,
G.Arcòvito,
M.De Spirito,
and
M.Rocco
(2002).
Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys,
66,
011913.
|
 |
|
|
|
|
 |
G.Tsurupa,
L.Tsonev,
and
L.Medved
(2002).
Structural organization of the fibrin(ogen) alpha C-domain.
|
| |
Biochemistry,
41,
6449-6459.
|
 |
|
|
|
|
 |
H.S.Park,
C.Kim,
and
Y.K.Kang
(2002).
Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets.
|
| |
Biopolymers,
63,
298-313.
|
 |
|
|
|
|
 |
K.Akassoglou,
and
S.Strickland
(2002).
Nervous system pathology: the fibrin perspective.
|
| |
Biol Chem,
383,
37-45.
|
 |
|
|
|
|
 |
S.Akhter,
A.Vignini,
Z.Wen,
A.English,
P.G.Wang,
and
B.Mutus
(2002).
Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation.
|
| |
Proc Natl Acad Sci U S A,
99,
9172-9177.
|
 |
|
|
|
|
 |
S.J.Everse
(2002).
New insights into fibrin (ogen) structure and function.
|
| |
Vox Sang,
83,
375-382.
|
 |
|
|
|
|
 |
Z.Yang,
G.Spraggon,
L.Pandi,
S.J.Everse,
M.Riley,
and
R.F.Doolittle
(2002).
Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide.
|
| |
Biochemistry,
41,
10218-10224.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Ferri,
M.Greco,
G.Arcovito,
F.A.Bassi,
M.De Spirito,
E.Paganini,
and
M.Rocco
(2001).
Growth kinetics and structure of fibrin gels.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys,
63,
031401.
|
 |
|
|
|
|
 |
J.Madrazo,
J.H.Brown,
S.Litvinovich,
R.Dominguez,
S.Yakovlev,
L.Medved,
and
C.Cohen
(2001).
Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution.
|
| |
Proc Natl Acad Sci U S A,
98,
11967-11972.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Yakovlev,
E.Makogonenko,
N.Kurochkina,
W.Nieuwenhuizen,
K.Ingham,
and
L.Medved
(2000).
Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
|
| |
Biochemistry,
39,
15730-15741.
|
 |
|
|
|
|
 |
Z.Yang,
I.Mochalkin,
L.Veerapandian,
M.Riley,
and
R.F.Doolittle
(2000).
Crystal structure of native chicken fibrinogen at 5.5-A resolution.
|
| |
Proc Natl Acad Sci U S A,
97,
3907-3912.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Yang,
I.Mochalkin,
and
R.F.Doolittle
(2000).
A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.
|
| |
Proc Natl Acad Sci U S A,
97,
14156-14161.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |